SVP, Head of Preclinical and Translational Development
Kojin Therapeutics
Boston, Massachusetts
Dr. Lakshmi Amaravadi serves as Senior Vice President and Head of Preclinical Development and Translational Medicine at Kojin Therapeutics. Lakshmi has nearly 30 years of R&D experience during which she contributed to several successful IND filings, clinical development and registration of multiple on market drugs. Her core expertise is in the area preclinical and clinical development, translational biomarkers, functional and cross-functional leadership. Her experience spans multiple therapeutic areas that include Oncology, Autoimmune, Metabolic diseases, Neurology, and rare diseases. Lakshmi is an internationally recognized expert in the translational biomarkers and bioanalytics (PK and immunogenicity), authored multiple white papers, collaborated with industry and regulatory leaders in developing best practices in this area. Lakshmi also holds leadership roles in professional associations such as American Association of Pharmaceuticals Scientists, where she is currently serving on the leadership of Biomarkers & Precision Medicine community. Prior to Kojin she held roles involving increasing area of responsibility at Biogen, Sanofi, Shire and at Boston Pharmaceuticals. She is also an elected Board Member of AAPS. She trained as a post-doctoral fellow at Walther Oncology Center, IUPUI and Eli Lilly after completing her Ph.D. in Molecular, Cell & Developmental Biology, Indiana State University.
Symposium: PD Biomarkers As Evidence in Rare Disease
Monday, October 23, 2023
9:00 AM – 11:00 AM ET